Distribution of Lymphatic Vessel Network in Normal Urinary Bladder

Urology

Volumn 72, Issue 3, 2008, Pages 706-710

  Matsumoto, Kazumasa ^a   Soh, Shigehiro ^a   Satoh, Takefumi ^a   Iwamura, Masatsugu ^a   Ishikawa, Yukio ^b   Ishii, Toshiharu ^b   Baba, Shiro ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GLYCOPROTEIN; LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1 ANTIBODY; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLADDER; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TOPOGRAPHY; UROTHELIUM;

AGED; ENDOTHELIUM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC VESSELS; MALE; MIDDLE AGED; URINARY BLADDER; UROTHELIUM; VESICULAR TRANSPORT PROTEINS; VON WILLEBRAND FACTOR;

EID: 50249101191     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.12.061     Document Type: Article

References (20)

1. Pollack A., Zagars G.K., Cole C.J., et al. The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol 154 (1995) 2059-2064
2. Lerner S.P., and Skinner D.G. Radical cystectomy for bladder cancer. In: Vogelzang N.J., Shipley W.U., Scardino P.T., et al. (Eds). Comprehensive Textbook of Genitourinary Oncology (1999), Lippincott Williams & Wilkins, Philadelphia 425-447
3. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
4. Dalbagni G., Genega E., Hashibe M., et al. Cystectomy for bladder cancer: a contemporary series. J Urol 165 (2001) 1111-1116
5. Schoenberg M.P. Management of invasive and metastatic bladder cancer. In: Walsh P.C., Retik A.B., Vaughan Jr. E.D., et al. (Eds). Campbell's Urology. 8th ed. vol 4 (2002), WB Saunders, Philadelphia 2803-2816
6. Quek M.L., Stein J.P., Clark P.E., et al. Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol 171 (2004) 640-645
7. Sleeman J.P., Krishnan J., Kirkin V., et al. Markers for the lymphatic endothelium: in search of the holy grail?. Microsc Res Tech 55 (2001) 61-69
8. Wetterwald A., Hoffstetter W., Cecchini M.G., et al. Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone 18 (1996) 125-132
9. Kaipainen A., Korhonen J., Mustonen T., et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92 (1995) 3566-3570
10. Soh S., Ishii T., Sato E., et al. Topographic distribution of lymphatic vessels in the normal human prostate. Prostate 63 (2005) 330-335
11. Akishima Y., Ito K., Zhang L., et al. Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody. Virchows Arch 444 (2004) 153-157
12. Fukuda H., Yamada T., Kamata S., et al. Anatomic distribution of intraprostatic lymphatics: implications for the lymphatic spread of prostate cancer-a preliminary study. Prostate 44 (2000) 322-337
13. Jackson D.G. The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc Med 13 (2003) 1-7
14. Furusato M., and Mostofi F.K. Intraprostatic lymphatics in man: light and ultrastructural observations. Prostate 1 (1980) 15-23
15. Sleeman J.P. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 157 (2000) 55-81
16. Stacker S.A., Achen M.G., Jussila L., et al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2 (2002) 573-583
17. Leissner J., Koeppen C., and Wolf H.K. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy. J Urol 169 (2003) 955-960
18. Lotan Y., Gupta A., Shariat S.F., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533-6539
19. Lerner S.P., Skinner D.G., Lieskovsky G., et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 149 (1993) 758-765
20. Yu R.J., Stein J.P., Cai J., et al. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. J Urol 176 (2006) 493-499